Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion type Assertion NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_head.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion wasGeneratedBy ECO_0000203 NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_provenance.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion wasDerivedFrom lhgdn-20090331 NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_provenance.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion SIO_000772 17650440 NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_provenance.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion evidence source_evidence_literature NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_provenance.
- NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_assertion description "[heterozygous carriers of FVL who experience an episode of venous thromboembolism (VTE) have on average a 40% increased risk of recurrent VTE over non-carriers; risk is lower with heterozygosity of prothrombin G20210A mutation [review]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227475.RAWN9TxaAtxbcyai_R7s9sUI_9PbLhHquttvgkSAX1ihU130_provenance.